Drew Dennison

Drew Dennison

Director/Board Member bij Sharpen Technologies, Inc.

Technology Services
Finance
Health Technology

Profiel

Drew Oconnor Dennison is currently the Director at Sharpen Technologies, Inc., the Managing Director at Lightchain Capital LLC, the Director at NextRNA Therapeutics, Inc., and the Director at AI Proteins, Inc. Previously, he held positions as the Director at Arch Oncology, Inc., the Director at Fintech Studios, Inc., the Chief Accounting Officer at Scottrade, Inc., and the Chief Operating & Financial Officer at Scottrade Financial Services, Inc. Mr. Dennison obtained his undergraduate degree from the University of Iowa.

Actieve functies van Drew Dennison

BedrijvenFunctieBegin
Director/Board Member -
Director/Board Member 01-03-2021
Director/Board Member -
Private Equity Investor -
Alle actieve functies van Drew Dennison

Eerdere bekende functies van Drew Dennison

BedrijvenFunctieEinde
Director of Finance/CFO 01-09-2017
Comptroller/Controller/Auditor 18-07-2012
Director/Board Member -
Director/Board Member -
Ervaring van Drew Dennison in detail bekijken

Opleiding van Drew Dennison

University of Iowa Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Drew Dennison in detail bekijken

Connecties

45

Eerstegraads connecties

9

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit8

Finance

Technology Services

Finance

Commercial Services

Technology Services

Technology Services

Health Technology

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Drew Dennison